NB
EW icon

Nicolet Bankshares’s Edwards Lifesciences EW Stock Holding History

Nicolet Bankshares’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$558K Buy
+6,917
New +$570K 0.02% 366

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nicolet Bankshares's EW Position: Q1 2026 in Review

Nicolet Bankshares opened a new position in Edwards Lifesciences (EW) in Q1 2026: 6,917 shares worth $558K. The stake represents 0.02% of the portfolio and ranks #366 among its holdings.

1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Nicolet Bankshares held 6,917 shares of Edwards Lifesciences worth $558K as of Q1 2026.
  • Edwards Lifesciences was a new Nicolet Bankshares position in Q1 2026.
  • Edwards Lifesciences made up 0.02% of Nicolet Bankshares's portfolio in Q1 2026, its #366 holding.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Nicolet Bankshares's 13F filing for Q1 2026, filed 14 May 2026.